Welcome to our dedicated page for HealWELL AI news (Ticker: HWAIF), a resource for investors and traders seeking the latest updates and insights on HealWELL AI stock.
HealWELL AI Inc. (HWAIF) is a leader in AI-powered healthcare solutions focused on improving preventative care through advanced clinical decision support systems. This page serves as the definitive source for official company updates, providing stakeholders with timely insights into strategic developments shaping the future of medical technology.
Investors and industry professionals will find curated press releases covering earnings announcements, strategic partnerships, and technology advancements. Our repository includes updates on regulatory milestones, research collaborations, and AI-driven product innovations that enhance early disease detection capabilities.
All content is rigorously verified to ensure accuracy and relevance for financial analysis and market research. Bookmark this page for direct access to HWAIF's latest progress in transforming healthcare through artificial intelligence and data science applications.
HEALWELL AI Inc. (TSX: AIDX, OTCQX: HWAIF) has announced significant changes to its executive leadership team effective July 1, 2025. James Lee will assume the role of CEO, while current CEO Dr. Alexander Dobranowski will transition to President. The company has also appointed Sacha Gera as Chief Operating Officer and Brad Porter as Chief Commercial Officer.
These strategic appointments follow HEALWELL's recent acquisition of Orion Health and reflect the company's shift towards its next growth phase, focusing on integrating its units and scaling its AI technology and health data interoperability capabilities globally. Under Dr. Dobranowski's leadership, HEALWELL completed six strategic acquisitions and raised over $100 million in capital.
The new executive team will focus on pursuing high-impact opportunities as a unified platform, with particular emphasis on integration, execution, and expanding the global potential of HEALWELL's AI and healthcare data solutions.
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) has completed the acquisition of Orion Health, a global healthcare intelligence platform, for NZD$175 million plus a potential NZD$25 million performance-based earn-out. The transaction combines Orion Health's data interoperability expertise with HEALWELL's AI technology to enhance healthcare outcomes.
Orion Health serves over 70 public and private sector customers, representing 150 million patient lives worldwide, with approximately 400 employees across 11 countries. The acquisition was funded through approximately $55 million from subscription receipts financings and up to $50 million in senior bank debt.
The purchase price included NZD$105 million in cash and NZD$70 million in HEALWELL shares. Following the transaction, HEALWELL has 261,547,371 shares outstanding on a non-diluted basis. The deal includes strategic appointments to HEALWELL's board, including Orion Health's founder Ian McRae.
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) announced that WELL Health Technologies Corp. plans to exercise its call option to acquire 61.6 million shares (30.8M Class A and 30.8M Class B) from existing shareholders. This action coincides with HEALWELL's acquisition of Orion Health Holdings , expected to complete on April 1, 2025.
Following the Orion Health acquisition, HEALWELL will have approximately 261.5 million Class A shares outstanding. After exercising the call option, WELL will own about 37.3% of economic interest and 69.6% of voting rights in HEALWELL. The deal grants WELL the ability to nominate a majority of HEALWELL's Board of Directors.
HEALWELL AI Inc. (TSX: AIDX) reported significant financial results for 2024, with record annual revenue of $39 million, representing a 433% increase from 2023. The company's Q4-2024 revenue reached $15.2 million, up 692% year-over-year.
A major highlight is the pending acquisition of Orion Health, expected to close on April 1, 2025. This acquisition, valued at NZD $175 million plus potential earnout of NZD $25 million, is anticipated to contribute over $100 million in annual revenues and make HEALWELL Adjusted EBITDA positive. The company has secured over $100 million in financing arrangements, including a recently signed $50 million credit agreement with Scotiabank and RBC.
However, HEALWELL reported an increased Adjusted EBITDA loss of $16 million for 2024, compared to $7.9 million in 2023. The company's gross margin improved to 44% in 2024 from 17% in 2023. Cash position stood at $9.4 million as of December 31, 2024.
HEALWELL AI Inc. (TSX: AIDX) reported exceptional growth in fiscal 2024, with annual revenue reaching $39 million, a 433% increase from 2023. Q4-2024 revenue hit $15.2 million, up 692% year-over-year.
The company announced a transformational acquisition of Orion Health Holdings , expected to close on April 1, 2025. Orion Health, with over 70 worldwide customers across 11 countries, is projected to contribute more than $100 million in annual revenues and make HEALWELL Adjusted EBITDA positive.
Key financial metrics for 2024 include:
- Gross Profit of $17.3 million (44% margin)
- Adjusted EBITDA loss of $1 million
- Cash position of $9.4 million as of December 31, 2024
To support the Orion acquisition, HEALWELL secured over $100 million in financing, including a $50 million credit agreement with Scotiabank and RBC, plus subscription receipt financings. The total purchase price is NZD 175 million plus a performance-based earnout of up to NZD 25 million.
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF), a healthcare artificial intelligence company specializing in preventative care, has scheduled the release of its Fourth Quarter and Year End 2024 financial results on Wednesday, March 26, 2025.
The company will host a conference call and simultaneous webcast to discuss the results for the period ended December 31, 2024, at 1:00 PM ET (10:00 AM PT). The presentation will be led by CEO Dr. Alexander Dobranowski and CFO Anthony Lam.
Participants can join via webcast or phone, with toll-free access available for North American callers at 1-833-752-3509 and international toll at 1-647-846-7993. Attendees are advised to dial in 10 minutes before the call start time.
HEALWELL AI Inc. (TSX: AIDX, OTCQX: HWAIF) has secured a $50 million credit agreement to support its acquisition of Orion Health. The credit facility, led by Scotiabank and RBC, includes a $20 million term loan and a $30 million revolving credit facility, with an additional uncommitted accordion feature of up to $25 million.
Combined with recent subscription receipt financings, HEALWELL has arranged over $100 million in total financing for the Orion Health acquisition. The company has initiated the pre-closing reorganization process by advancing NZD$5 million to the vendor, targeting a closing date of April 1, 2025.
Orion Health is a global Healthcare Intelligence Platform serving approximately 150 million lives across 11 countries. The acquisition will expand HEALWELL's footprint in preventative care and AI-driven healthcare solutions, particularly strengthening its presence in the public sector through Orion's government relationships.
HEALWELL AI (TSX: AIDX, OTCQX: HWAIF), a healthcare AI company specializing in preventative care, has announced its participation in two major upcoming investor conferences.
The company will first attend the 28th Annual Scotiabank TMT Conference on March 4-5, 2025, in Toronto. CEO Dr. Alexander Dobranowski will deliver a presentation on March 5 at 12:25 PM ET and participate in a keynote panel discussion titled 'AI and the Digital Health Ecosystem: Building a Smarter Future.'
Subsequently, HEALWELL will participate in the 37th Annual ROTH Conference from March 16-18, 2025, in Dana Point, California. This event, one of North America's largest small-cap gatherings, will feature approximately 450 companies across various growth sectors. Dr. Dobranowski will conduct one-on-one meetings with investors to discuss HEALWELL's AI-powered healthcare solutions and preventative care vision.
HEALWELL AI (TSX: AIDX, OTCQX: HWAIF) has announced that its subsidiary VeroSource Solutions has launched new Digital Twin functionality on its VS Data-as-a-Service Platform. The technology creates a virtual representation of healthcare facilities, enabling real-time analysis and prediction without disrupting operations.
The Digital Twin system features seamless data integration of HL7 and ERP data, dynamic virtual modeling for real-time facility visualization, and enhanced decision-making capabilities. It incorporates population demographics, disease trends, and external factors to help healthcare professionals optimize operations, reduce costs, and improve patient care.
VeroSource's platform securely integrates health data from various sources including EMRs, pharmacies, and hospital information systems into a single platform. The infrastructure is fully compatible with HEALWELL's AI capabilities, allowing for expansion of digital co-pilot tools and data visualization across both companies' footprints.
HEALWELL AI's subsidiary Khure Health reported significant growth in Q4-2024, with its AI-Powered Physician Co-Pilots helping identify over 43,000 high-risk patients across 8 clinical specialties using 132 disease-specific algorithms. This represents a 22% quarter-over-quarter growth and 500% year-over-year growth compared to Q4-2023.
The company secured 4 new Master Services Agreements with pharmaceutical partners in Q4-2024, bringing the total to 16 MSAs, including partnerships with 7 of the world's 10 largest pharmaceutical companies. Khure's physician survey revealed an Net Promoter Score (NPS) of 84, with 82% of physicians confirming improved patient care through the AI technology.
HEALWELL has now onboarded over 800 physicians using its Khure Co-Pilots, with the WELL AI Decision Support (WAIDS) Program being the fastest-growing component, representing approximately 80% of new physician onboarding in Q4.
